Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model

ABSTRACT Porphyromonas gingivalis (P. gingivalis), a gram-negative, black-pigmented anaerobe, is a major etiological agent and a leading cause of periodontitis. Fimbriae protein Mfa1 is a key virulence factor of P. gingivalis and plays a crucial role in bacterial adhesion, colonization, biofilm form...

Full description

Saved in:
Bibliographic Details
Main Authors: Mingya Cao, Siyu Wang, Shengke Zhou, Min Yan, Yu Zou, Yuan Cui, Xinyu Lou, Yichang Gao, Ying Chen, Zijing Han, Yi Qian, Jingying Chen, Xia Li
Format: Article
Language:English
Published: American Society for Microbiology 2025-01-01
Series:mSphere
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/msphere.00721-24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832583444194918400
author Mingya Cao
Siyu Wang
Shengke Zhou
Min Yan
Yu Zou
Yuan Cui
Xinyu Lou
Yichang Gao
Ying Chen
Zijing Han
Yi Qian
Jingying Chen
Xia Li
author_facet Mingya Cao
Siyu Wang
Shengke Zhou
Min Yan
Yu Zou
Yuan Cui
Xinyu Lou
Yichang Gao
Ying Chen
Zijing Han
Yi Qian
Jingying Chen
Xia Li
author_sort Mingya Cao
collection DOAJ
description ABSTRACT Porphyromonas gingivalis (P. gingivalis), a gram-negative, black-pigmented anaerobe, is a major etiological agent and a leading cause of periodontitis. Fimbriae protein Mfa1 is a key virulence factor of P. gingivalis and plays a crucial role in bacterial adhesion, colonization, biofilm formation, and persistent inflammation, making it a promising therapeutic target. However, the role of anti-Mfa1 antibodies and the underlying protective mechanisms remain largely unexplored. Here, we developed and characterized the monoclonal antibodies (mAbs) targeting the Mfa1 protein of P. gingivalis. Function analysis showed that anti-Mfa1 mAbs mediated bacterial agglutination and inhibited P. gingivalis adhesion to saliva-coated hydroxyapatite and host cells. Notably, anti-Mfa1 mAbs significantly reduced bacterial burden and alveolar bone loss in a P. gingivalis-induced experimental periodontitis model. These results show that anti-Mfa1 mAbs can be beneficial in alleviating P. gingivalis infections, and provide important insights for the development of adequate adjuvant treatment regimens for Mfa1-targeted therapeutics.IMPORTANCEFimbriae (pili) play an important role in bacterial adhesion, invasion of host cells and tissues, and formation of biofilms. Studies have shown that two types of fimbriae of Porphyromonas gingivalis, FimA and Mfa1, are important for colonization and infection through their binding to host tissues and other bacteria. While anti-FimA antibodies have been shown to improve periodontitis, the effect of anti-Mfa1 antibodies on P. gingivalis infection and periodontitis was previously unknown. In this study, we report for the first time that anti-Mfa1 monoclonal antibodies can reduce P. gingivalis infection and improve periodontitis. These findings suggest that Mfa1 represents a promising therapeutic target, and the development of anti-Mfa1 mAbs holds a potential as essential diagnostic and adjunctive therapeutic tools for managing P. gingivalis-related diseases.
format Article
id doaj-art-efd74c76b52142d483657b4a155205b3
institution Kabale University
issn 2379-5042
language English
publishDate 2025-01-01
publisher American Society for Microbiology
record_format Article
series mSphere
spelling doaj-art-efd74c76b52142d483657b4a155205b32025-01-28T14:00:56ZengAmerican Society for MicrobiologymSphere2379-50422025-01-0110110.1128/msphere.00721-24Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis modelMingya Cao0Siyu Wang1Shengke Zhou2Min Yan3Yu Zou4Yuan Cui5Xinyu Lou6Yichang Gao7Ying Chen8Zijing Han9Yi Qian10Jingying Chen11Xia Li12Joint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaThe First Affiliated Hospital of Henan University, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaJoint National Laboratory for Antibody Drug Engineering, School of Medicine, Henan University, Kaifeng, ChinaABSTRACT Porphyromonas gingivalis (P. gingivalis), a gram-negative, black-pigmented anaerobe, is a major etiological agent and a leading cause of periodontitis. Fimbriae protein Mfa1 is a key virulence factor of P. gingivalis and plays a crucial role in bacterial adhesion, colonization, biofilm formation, and persistent inflammation, making it a promising therapeutic target. However, the role of anti-Mfa1 antibodies and the underlying protective mechanisms remain largely unexplored. Here, we developed and characterized the monoclonal antibodies (mAbs) targeting the Mfa1 protein of P. gingivalis. Function analysis showed that anti-Mfa1 mAbs mediated bacterial agglutination and inhibited P. gingivalis adhesion to saliva-coated hydroxyapatite and host cells. Notably, anti-Mfa1 mAbs significantly reduced bacterial burden and alveolar bone loss in a P. gingivalis-induced experimental periodontitis model. These results show that anti-Mfa1 mAbs can be beneficial in alleviating P. gingivalis infections, and provide important insights for the development of adequate adjuvant treatment regimens for Mfa1-targeted therapeutics.IMPORTANCEFimbriae (pili) play an important role in bacterial adhesion, invasion of host cells and tissues, and formation of biofilms. Studies have shown that two types of fimbriae of Porphyromonas gingivalis, FimA and Mfa1, are important for colonization and infection through their binding to host tissues and other bacteria. While anti-FimA antibodies have been shown to improve periodontitis, the effect of anti-Mfa1 antibodies on P. gingivalis infection and periodontitis was previously unknown. In this study, we report for the first time that anti-Mfa1 monoclonal antibodies can reduce P. gingivalis infection and improve periodontitis. These findings suggest that Mfa1 represents a promising therapeutic target, and the development of anti-Mfa1 mAbs holds a potential as essential diagnostic and adjunctive therapeutic tools for managing P. gingivalis-related diseases.https://journals.asm.org/doi/10.1128/msphere.00721-24periodontitisP. gingivalismonoclonal antibodiesfimbriaeMfa1
spellingShingle Mingya Cao
Siyu Wang
Shengke Zhou
Min Yan
Yu Zou
Yuan Cui
Xinyu Lou
Yichang Gao
Ying Chen
Zijing Han
Yi Qian
Jingying Chen
Xia Li
Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
mSphere
periodontitis
P. gingivalis
monoclonal antibodies
fimbriae
Mfa1
title Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
title_full Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
title_fullStr Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
title_full_unstemmed Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
title_short Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
title_sort development of monoclonal antibodies against p gingivalis mfa1 and their protective capacity in an experimental periodontitis model
topic periodontitis
P. gingivalis
monoclonal antibodies
fimbriae
Mfa1
url https://journals.asm.org/doi/10.1128/msphere.00721-24
work_keys_str_mv AT mingyacao developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT siyuwang developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT shengkezhou developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT minyan developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT yuzou developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT yuancui developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT xinyulou developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT yichanggao developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT yingchen developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT zijinghan developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT yiqian developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT jingyingchen developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel
AT xiali developmentofmonoclonalantibodiesagainstpgingivalismfa1andtheirprotectivecapacityinanexperimentalperiodontitismodel